Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

NCT07516418 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)
Influenza A(H5N1)

Interventions

BIOLOGICAL: H5 Flu Investigational Medical Product (IMP) 1
BIOLOGICAL: H5 Flu IMP 2
BIOLOGICAL: H5 Flu IMP 3
BIOLOGICAL: RSV IMP 4
BIOLOGICAL: RSV IMP 5
BIOLOGICAL: RSV IMP 6
BIOLOGICAL: H5 Flu IMP 7
BIOLOGICAL: H5 Flu IMP 8
BIOLOGICAL: H5 Flu IMP 9
BIOLOGICAL: H5 Flu IMP 10
BIOLOGICAL: H5 Flu IMP 11
BIOLOGICAL: H5 Flu IMP 12

Sponsor

Sanofi